Atai Life Sciences Stock Performance
| ATAI Stock | USD 3.84 0.04 1.05% |
The firm owns a Beta (Systematic Risk) of 2.46, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ATAI Life will likely underperform. At this point, ATAI Life Sciences has a negative expected return of -0.23%. Please make sure to confirm ATAI Life's value at risk, rate of daily change, and the relationship between the total risk alpha and kurtosis , to decide if ATAI Life Sciences performance from the past will be repeated in the future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days ATAI Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
| Begin Period Cash Flow | 45 M | |
| Total Cashflows From Investing Activities | 59.2 M |
ATAI Life Relative Risk vs. Return Landscape
If you would invest 483.00 in ATAI Life Sciences on August 26, 2025 and sell it today you would lose (99.00) from holding ATAI Life Sciences or give up 20.5% of portfolio value over 90 days. ATAI Life Sciences is currently does not generate positive expected returns and assumes 5.1009% risk (volatility on return distribution) over the 90 days horizon. In different words, 45% of stocks are less volatile than ATAI, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ATAI Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ATAI Life's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ATAI Life Sciences, and traders can use it to determine the average amount a ATAI Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0455
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ATAI |
Estimated Market Risk
| 5.1 actual daily | 45 55% of assets are more volatile |
Expected Return
| -0.23 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ATAI Life is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ATAI Life by adding ATAI Life to a well-diversified portfolio.
ATAI Life Fundamentals Growth
ATAI Stock prices reflect investors' perceptions of the future prospects and financial health of ATAI Life, and ATAI Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ATAI Stock performance.
| Return On Equity | -1.01 | |||
| Return On Asset | -0.29 | |||
| Operating Margin | (37.97) % | |||
| Current Valuation | 1.27 B | |||
| Shares Outstanding | 363.19 M | |||
| Price To Earning | 0.30 X | |||
| Price To Book | 8.65 X | |||
| Price To Sales | 457.30 X | |||
| Revenue | 308 K | |||
| EBITDA | (144.81 M) | |||
| Cash And Equivalents | 304.06 M | |||
| Cash Per Share | 1.83 X | |||
| Total Debt | 24.71 M | |||
| Debt To Equity | 0.06 % | |||
| Book Value Per Share | 0.73 X | |||
| Cash Flow From Operations | (82.44 M) | |||
| Earnings Per Share | (0.83) X | |||
| Total Asset | 159.39 M | |||
| Retained Earnings | (700.21 M) | |||
| Current Asset | 320.15 M | |||
| Current Liabilities | 74.35 M | |||
About ATAI Life Performance
By evaluating ATAI Life's fundamental ratios, stakeholders can gain valuable insights into ATAI Life's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ATAI Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ATAI Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany. Atai Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people.Things to note about ATAI Life Sciences performance evaluation
Checking the ongoing alerts about ATAI Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ATAI Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ATAI Life Sciences generated a negative expected return over the last 90 days | |
| ATAI Life Sciences has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 308 K. Net Loss for the year was (150.05 M) with profit before overhead, payroll, taxes, and interest of 3.02 M. | |
| ATAI Life Sciences currently holds about 304.06 M in cash with (82.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.83. |
- Analyzing ATAI Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ATAI Life's stock is overvalued or undervalued compared to its peers.
- Examining ATAI Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ATAI Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ATAI Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ATAI Life's stock. These opinions can provide insight into ATAI Life's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ATAI Stock analysis
When running ATAI Life's price analysis, check to measure ATAI Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATAI Life is operating at the current time. Most of ATAI Life's value examination focuses on studying past and present price action to predict the probability of ATAI Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATAI Life's price. Additionally, you may evaluate how the addition of ATAI Life to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |